The Association between a Decrease in On-Treatment Neutrophil-to-Eosinophil Ratio (NER) at Week 6 after Ipilimumab Plus Nivolumab Initiation and Improved Clinical Outcomes in Metastatic Renal Cell Carcinoma.

Cancers (Basel) · 2022 · PMC9367298 · PMID 35954493

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

NER decrease ≤50% at week 6 showed a trend toward improved PFS (AHR:0.63, 95% CI:0.38–1.05, p -value: 0.07) and OS (AHR: 0.49, 95% CI: 0.23–1.06, p -value: 0.07).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.